Philip Morris International (PMI) has concluded its controversial £1.1bn takeover of UK health firm Vectura, becoming its majority shareholder, along with that of the Danish oral-products manufacturer Fertin Pharma.
Confirming the completion of the deal today, Vectura, which develops and manufactures inhalers, said that the offer from the Big Tobacco company –£1.65 per share – now becomes “unconditional in all respects”, meaning the remaining stakeholders cannot prevent it.
...
Need help?
Contact a sales representative right now and don’t wait
“ Healthy business? PMI completes its takeover of Vectura and Fertin Pharma ”
Buy report request information:
“ Healthy business? PMI completes its takeover of Vectura and Fertin Pharma ”
Philip Morris International (PMI) has concluded its controversial £1.1bn takeover of UK health firm Vectura, becoming its majority shareholder, along with that of the Danish oral-products manufacturer Fertin Pharma.
Confirming the completion of the deal today, Vectura, which develops and manufactures inhalers, said that the offer from the Big Tobacco company –£1.65 per share – now becomes “unconditional in all respects”, meaning the remaining stakeholders cannot prevent it.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Benefits of subscription plans:
Stay informed of any legal and market change in the sector that impacts your organization
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Need help?
Contact a sales representative right now and don’t wait
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
LATEST ALERTS
